Carboxymethyl benzylamide dextrans inhibit breast cell growth

No abstract is available for this paper.

• Publication year

  1994

• Venue

  In Vitro Cellular & Developmental Biology - Animal

• Publication date

  1994-12-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/BF02639391PMID 7534590
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In vitro stimulation of human endothelial cells by derivatized dextrans

  2007cited by this paper
• Inhibition of growth factor binding and intracellular Ca2+ signalling by dextran sulfates of different sizes and degrees of sulfation

  2004cited by this paper
• Suramin interrupts androgen‐inducible autocrine loop involving heparin binding growth factor in mouse mammary cancer (Shionogi carcinoma 115) cells

  1993cited by this paper
• Antiproliferative capacity of synthetic dextrans on smooth muscle cell growth: the model of derivatized dextrans as heparin-like polymers.

  1993cited by this paper
• Inhibitory effect of substituted dextrans on MCF7 human breast cancer cell growth in vitro

  1992cited by this paper
• Suramin inhibits the growth of human rhabdomyosarcoma by interrupting the insulin-like growth factor II autocrine growth loop.

  1992cited by this paper
• Inhibitory effects of dextran derivatives in vitro on the growth characteristics of premalignant and malignant human mammary epithelial cell lines.

  1992cited by this paper
• Tumor growth dependent on Kaposi's sarcoma-derived fibroblast growth factor inhibited by pentosan polysulfate.

  1991cited by this paper
• Derivatized dextran inhibition of smooth muscle cell proliferation.

  1991cited by this paper
• Suramin inhibits proliferation of rat glioma cells and alters N‐cam cell surface expression

  1990cited by this paper
• Heparin prevents vascular smooth muscle cell progression through the G1 phase of the cell cycle.

  1989cited by this paper
• Molecular weight dependency of the acquired anticomplementary and anticoagulant activities of specifically substituted dextrans.

  1987cited by this paper
• Suramin inhibition of growth factor receptor binding and mitogenicity in AKR‐2B cells

  1987cited by this paper
• Inhibition of rat cervical epithelial cell growth by heparin and its reversal by EGF

  1985cited by this paper
• Anticoagulant activity of dextran derivatives. Part I: Synthesis and characterization.

  1984cited by this paper
• Effect of Collagen and Acid Polysaccharides on the Growth of BHK/21 Cells in Semi-solid Media

  1970cited by this paper

• Functional Polymers Based on Dextran

  2006cites this paper
• Inhibition of MCF-lras Tumor Growth by Carboxymethyl Benzylamide Dextran : Blockage of the Paracrine Effect and Receptor Binding of Transforming Growth Factor 31 and Platelet-derived Growth Factor-BB 1

  2005cites this paper
• Growth inhibition of MCF-7 tumor cell line by phenylacetate linked to functionalized dextran

  2004cites this paper
• Aponecrotic, antiangiogenic and antiproliferative effects of a novel dextran derivative on breast cancer growth in vitro and in vivo

  2002cites this paper
• Growth inhibition of human melanoma tumor cells by the combination of sodium phenylacetate (NaPA) and substituted dextrans and one NaPA–dextran conjugate

  2002cites this paper
• Carboxymethyl benzylamide dextran and tamoxifen combination inhibits tumor growth and angiogenesis.

  2001cites this paper
• Breast carcinoma cell uptake and biodistribution of technetium-99m-carboxymethyl benzylamide dextran.

  2001cites this paper
• Low-molecular-weight dextran derivatives (f-CMDB) enter the nucleus and are better cell-growth inhibitors compared with parent CMDB polymers.

  1999cites this paper
• Carboxymethyl benzylamide dextran blocks angiogenesis of MDA-MB435 breast carcinoma xenografted in fat pad and its lung metastases in nude mice.

  1999cites this paper
• Effects of the binding of a dextran derivative on fibroblast growth factor 2: secondary structure and receptor-binding studies.

  1999cites this paper
• Carboxymethyl benzylamide sulfonate dextrans (CMDBS), a family of biospecific polymers endowed with numerous biological properties: a review.

  1999cites this paper
• Inhibition of MCF-7ras tumor growth by carboxymethyl benzylamide dextran: blockage of the paracrine effect and receptor binding of transforming growth factor beta1 and platelet-derived growth factor-BB.

  1998cites this paper
• The suppression of fibroblast growth factor 2/fibroblast growth factor 4-dependent tumour angiogenesis and growth by the anti-growth factor activity of dextran derivative (CMDB7).

  1998cites this paper
• Modulations of breast fibroblast and carcinoma cell interactions by a dextran derivative (CMDB7).

  1997cites this paper
• Inhibition of human breast epithelial HBL100 cell proliferation by a dextran derivative (CMDB7): interference with the FGF2 autocrine loop [corrected].

  1997cites this paper
• Affinity chromatography of human anti-dextran antibodies. Isolation of two distinct populations.

  1996cites this paper